Active ingredientUpadacitinibCat. No. P-U008-001CAS 1310726-60-3Family · Pharmaceutical analytical standards
Upadacitinib
A selective JAK1 kinase inhibitor, approved in 2019 in the United States and Europe for rheumatoid arthritis, and later for psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease and axial spondyloarthritis. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It is a second-generation JAK inhibitor that favours JAK1: it is about 74 times more selective for JAK1 than for JAK2 and 58 times more than for JAK3.
Go to the active ingredient →Active ingredientUpadacitinibCat. No. P-U008-001CAS 1310726-60-3
Active ingredientUpadacitinib TartrateCat. No. P-U008-002
MetaboliteM11 Metabolite of UpadacitinibCat. No. P-U008-003
Isotopically labelledUpadacitinib Impurity 48-d5Cat. No. P-U008-004
Isotopically labelledUpadacitinib-15N-d2Cat. No. P-U008-005
Isotopically labelledUpadacitinib-d5Cat. No. P-U008-007
NitrosamineN1-Nitroso UpadacitinibCat. No. P-U008-008
NitrosamineN2-Nitroso UpadacitinibCat. No. P-U008-009
NitrosamineN-Nitroso Upadacitinib Impurity 1Cat. No. P-U008-010
NitrosamineN-Nitroso Upadacitinib Impurity 2Cat. No. P-U008-011
ImpurityUpadacitinib Impurity 1Cat. No. P-U008-013CAS 1869118-25-1
ImpurityUpadacitinib Impurity 2Cat. No. P-U008-014CAS 1201186-54-0![5-Tosyl-5H-pyrrolo[2,3-b]pyrazin-2-amine](https://img.vitasanlabs.com/vsl-struct/P-U008-015.svg?v=41e934f030)
Impurity5-Tosyl-5H-pyrrolo[2,3-b]pyrazin-2-amineCat. No. P-U008-015CAS 1201187-46-3![5-Tosyl-5H-pyrrolo[2,3-b]pyrazine](https://img.vitasanlabs.com/vsl-struct/P-U008-016.svg?v=41e934f030)
Impurity5-Tosyl-5H-pyrrolo[2,3-b]pyrazineCat. No. P-U008-016CAS 1944483-53-7![5H-pyrrolo[2,3-b]pyrazin-2-amine](https://img.vitasanlabs.com/vsl-struct/P-U008-017.svg?v=41e934f030)
Impurity5H-pyrrolo[2,3-b]pyrazin-2-amineCat. No. P-U008-017CAS 1504066-86-7
ImpurityUpadacitinib Impurity 3Cat. No. P-U008-018CAS 1428243-26-8
ImpurityUpadacitinib Impurity 4Cat. No. P-U008-019CAS 2460133-49-5
ImpurityUpadacitinib Impurity 5Cat. No. P-U008-020CAS 2868258-96-0
ImpurityUpadacitinib Impurity 6Cat. No. P-U008-021CAS 1428243-69-9
ImpurityUpadacitinib Impurity 7Cat. No. P-U008-024CAS 1869118-24-0
ImpurityUpadacitinib Impurity 8Cat. No. P-U008-025CAS 1046861-47-5
ImpurityUpadacitinib Impurity 9Cat. No. P-U008-026CAS 1201187-44-1
ImpurityUpadacitinib Cyclized ImpurityCat. No. P-U008-027CAS 1708997-42-5
ImpurityUpadacitinib Des Tosyl ImpurityCat. No. P-U008-028CAS 2095311-51-4
ImpurityUpadacitinib EnantiomerCat. No. P-U008-031CAS 1310726-59-0
ImpurityUpadacitinib Impurity 10Cat. No. P-U008-032
ImpurityUpadacitinib Impurity 11Cat. No. P-U008-033
ImpurityUpadacitinib Impurity 12Cat. No. P-U008-034
ImpurityUpadacitinib Impurity 13Cat. No. P-U008-035
ImpurityUpadacitinib Impurity 14Cat. No. P-U008-036
ImpurityUpadacitinib Impurity 15Cat. No. P-U008-038
ImpurityUpadacitinib Impurity 16Cat. No. P-U008-039
ImpurityUpadacitinib Impurity 17Cat. No. P-U008-040
ImpurityUpadacitinib Impurity 18Cat. No. P-U008-041
ImpurityUpadacitinib Impurity 19Cat. No. P-U008-042
ImpurityUpadacitinib Impurity 20Cat. No. P-U008-043
ImpurityUpadacitinib Impurity 21Cat. No. P-U008-044
ImpurityUpadacitinib Impurity 22Cat. No. P-U008-045CAS 2715120-86-6
ImpurityUpadacitinib Impurity 23Cat. No. P-U008-046
ImpurityUpadacitinib Impurity 24Cat. No. P-U008-047
ImpurityUpadacitinib Impurity 25Cat. No. P-U008-048
ImpurityUpadacitinib Impurity 26Cat. No. P-U008-049
ImpurityUpadacitinib Impurity 27Cat. No. P-U008-050
ImpurityUpadacitinib Impurity 28Cat. No. P-U008-051
ImpurityUpadacitinib Impurity 29Cat. No. P-U008-052
ImpurityUpadacitinib Impurity 30Cat. No. P-U008-053CAS 2050038-81-6
ImpurityUpadacitinib Impurity 31Cat. No. P-U008-054CAS 2715120-95-7
ImpurityUpadacitinib Impurity 32Cat. No. P-U008-055CAS 1428243-28-0
ImpurityUpadacitinib Impurity 33Cat. No. P-U008-056
ImpurityUpadacitinib Impurity 34Cat. No. P-U008-057
ImpurityUpadacitinib Impurity 35Cat. No. P-U008-058
ImpurityUpadacitinib Impurity 36Cat. No. P-U008-059
ImpurityUpadacitinib Impurity 37Cat. No. P-U008-060
ImpurityUpadacitinib Impurity 38Cat. No. P-U008-061
ImpurityUpadacitinib Impurity 39Cat. No. P-U008-062CAS 1428243-27-9
ImpurityUpadacitinib Impurity 40Cat. No. P-U008-063CAS 2050038-78-1
ImpurityUpadacitinib Impurity 41Cat. No. P-U008-064
ImpurityUpadacitinib Impurity 42Cat. No. P-U008-065CAS 2270173-63-0
ImpurityUpadacitinib Impurity 43Cat. No. P-U008-067
ImpurityUpadacitinib Impurity 44Cat. No. P-U008-068
ImpurityUpadacitinib Impurity 45Cat. No. P-U008-070
ImpurityUpadacitinib Impurity 46Cat. No. P-U008-071
ImpurityUpadacitinib Impurity 47Cat. No. P-U008-072
ImpurityUpadacitinib Impurity 48Cat. No. P-U008-074CAS 1708997-43-6
ImpurityUpadacitinib Impurity 49Cat. No. P-U008-075CAS 2768445-17-4
ImpurityUpadacitinib Impurity 50Cat. No. P-U008-076
ImpurityUpadacitinib Impurity 51Cat. No. P-U008-077
ImpurityUpadacitinib Impurity 52Cat. No. P-U008-078No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.